NYKODE
LIVE

Serial Number

79337526

Owner

NYKODE THERAPEUTICS ASA

Attorney

Christian D. Abel

Filing Date

Nov 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NYKODE Trademark

Serial Number: 79337526 • Registration: 7185056

NYKODE is a trademark filed by NYKODE THERAPEUTICS ASA on November 29, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

NYKODE THERAPEUTICS ASA (4 trademarks)

Gaustadalléen 21

Entity Type: 99

ONSAGERS AS (4 trademarks)

Postboks 1813, Vika

Entity Type: 99

Trademark Details

Filing Date

November 29, 2021

Registration Date

October 10, 2023

Published for Opposition

July 25, 2023

Goods & Services

Treatment of biological materials for use in production of pharmaceutical preparations by means of culturing, expansion, filtration, purification, addition of pharmaceutical excipients and carriers, as well as the portioning and packing of those materials; processing and custom manufacturing of pharmaceuticals for others; processing and custom manufacturing of preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations for others

Laboratory instruments and apparatus for analyzing nucleic acids, DNA, RNA, peptides, proteins, lipids, polysaccharides, antigens and antigen presenting cells, for preparation, filtration and separation of nucleic acids, DNA, RNA, peptides, proteins, lipids, poly saccharides, antigens and antigen presenting cells, and for chromatography, not for medical purposes; Downloadable medical software and mobile application for use with immunotherapy, namely, compiling medical data, analyzing test results, and evaluating medical data; Downloadable medical software for designing pharmaceuticals; Downloadable medical software and mobile applications allowing user selection of antigens for designing personalized medicines; Downloadable medical software and mobile applications for user selection of antigens for designing pharmaceuticals

Pharmaceuticals and veterinary preparations for treatment of immune diseases, cancer, tumors, infectious diseases and viral diseases; sanitary preparations for medical purposes; dietary supplements for humans and animals; Immunotherapeutic preparations, namely, vaccines against immune diseases, cancer, tumors, infectious diseases and viral diseases; Pharmaceutical preparations for the treatments of cancer; Pharmaceutical preparations for treatment of tumors; anti-cancer pharmaceutical preparations for injections; Radioactive pharmaceutical preparations for radiation treatment; Radioactive substances for medical purposes; Diagnostic preparations for medical and veterinary purposes; pharmaceutical preparations for treatment of infectious diseases; pharmaceutical preparations for treatment of viral diseases; Biological preparations for medical purposes, namely, the treatment of immune diseases, cancer, tumors, infectious diseases and viral diseases; biological preparations for treatment of cancer; biological preparations for treatment of infectious diseases; biological preparations for treatment of viral diseases; vaccines; immunostimulants; pharmaceutical preparations for treatment of allergies; biological preparations for treatment of allergies; pharmaceutical preparations for treatment of autoimmune diseases; biological preparations for treatment of autoimmune diseases

Promoting the goods of others, namely, pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products; retail store services featuring pharmaceutical products, biological preparations, medical diagnostic products, vaccines, anti-cancer pharmaceutical products, and immunotherapeutic pharmaceuticals and products

Providing information in the field of medicine and health in related to the treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical and pharmaceutical consulting services in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; Provision of medical services by health care professions, namely, hygiene care for human beings in the field of treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and diagnostic preparations; medical clinic services

Scientific and technological laboratory services and research and design relating thereto, all in the field of pharmaceuticals and vaccines; Industrial analysis and research services in the field of pharmaceuticals and vaccines; design and development of computer hardware and software; design, research and development of pharmaceuticals, preparations for cancer treatment, preparations for treatment of tumors, immunotherapeutic preparations, anti-cancer preparations for injection, radioactive preparations for radiation treatment, radioactive pharmaceuticals, vaccines, preparations for treatment of viral diseases, preparations for treatment of allergies, preparations for treatment of autoimmune diseases, immunostimulants, biological preparations for treatment of cancer, biological preparations for treatment of viral diseases, biological preparations for treatment of allergies, biological preparations for treatment of autoimmune diseases and medical diagnostic preparations; design and development of medical diagnostic equipment and medical instruments; research and development in the field of medical diagnostic preparations; design and development of medical techniques; Pharmaceutical research and development; Scientific and technological consultancy related to the aforesaid services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 11, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 11, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 10, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 10, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 13, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2023 CNEA
EXAMINER'S AMENDMENT ENTERED
Jun 12, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 12, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 12, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 12, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2023 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 4, 2023 ADCH
REFUSAL PROCESSED BY IB
Dec 22, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 26, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 26, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 30, 2022 ADCH
CHANGE OF OWNER RECEIVED FROM IB
May 8, 2022 CHLD
APPLICATION FILING RECEIPT MAILED
Apr 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 7, 2022 REPR